PTHS Earnings Date: Nov 12, 2026 (Estimated) — Pelthos Therapeutics Inc.
AMEX · Healthcare · Biotechnology
Updated
When is PTHS's next earnings date?
Pelthos Therapeutics Inc. (PTHS) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$3.08 on revenue of $16.9M.
How did PTHS do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Pelthos Therapeutics Inc. posted EPS of -$6.62 versus the -$2.82 estimate, a miss of 123.6%. Revenue was $15.6M against a $15.2M estimate. The stock's 1-day post-earnings move was +0.1%.
How much does PTHS stock move after earnings?
PTHS beat EPS estimates in 2 of its last 5 reported quarters. Over the last 5 reports the stock moved an average of 4.6% (up or down) in the day after earnings.
About Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. operates as a biopharmaceutical enterprise dedicated to developing and commercializing innovative medical treatments that address significant, unmet patient needs. Its primary offerings include ZELSUVMI, a medication specifically indicated for the treatment of molluscum contagiosum in individuals aged one year and older. Furthermore, the company leverages NITRICIL, an exclusive technological platform grounded in nitric oxide research. Established in 2002, this Durham, North Carolina-based firm was previously known as Channel Therapeutics Corporation, before rebranding to Pelthos Therapeutics Inc. in July 2025.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -2.82 | -6.62 | -123.65% | $15.6M | ❌ Miss | +0.14% | -10.69% | -24.25% |
| 2026-05-14 | Q1 2026 | -3.66 | -3.09 | +15.57% | $10.9M | ✅ Beat | +6.46% | +4.23% | +5.73% |
| 2026-03-19 | Q4 2025 | -4.09 | -6.87 | -67.97% | $9.4M | ❌ Miss | -4.62% | -8.26% | -4.42% |
| 2025-11-13 | Q3 2025 | -0.67 | -5.30 | -691.04% | $7.4M | ❌ Miss | -7.27% | -19.76% | -38.53% |
| 2025-08-13 | Q2 2025 | -6.26 | -5.38 | +14.06% | $0 | ✅ Beat | +4.29% | +17.77% | +78.71% |
Showing last 5 quarters.